placeholder image
C. J. Levy All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2024
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System. 
    Diabetes Research and Clinical Practice. 2022
  • Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations. 
    Diabetes Technology & Therapeutics. 2022
  • Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D exchange. 
    Journal of Diabetes and Its Complications. 2022
  • First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes. 
    Diabetes Technology & Therapeutics. 2021
  • Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study. 
    Journal of Diabetes Science and Technology. 2021
  • Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion. 
    Diabetes Technology & Therapeutics. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. 
    Diabetes care. 2021
    • Conference Poster
  • Autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D Exchange [poster]
    2019
    • Review
  • Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review]. 
    Diabetes Technology & Therapeutics. 2023
  • What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review]. 
    Diabetes Technology & Therapeutics. 2021
    • Abstract
  • First home evaluation of the Omnipod Horizon automated glucose control system at specific glucose targets in children with type 1 diabetes [abstract]. 
    Diabetes. 2020
    • Contact
    full name
  • C. J. Levy
    • Quick Info
     
    Collaboration